Authors: Woon H. Chong,a,⁎Biplab K. Saha,bKurt Hu,c and Amit Chopraa Abstract Background Pneumothorax has been frequently described as a complication of COVID-19 infections. Objective In this systematic review, we describe the incidence, […]
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Authors: Timothy Cardozo 1 and Ronald Veazey 2 Abstract Aims of the study Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the […]
U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post
Authors: Reporting by Shubham Kalia in Bengaluru; Editing by Krishna Chandra Eluri and Ramakrishnan M. Aug 19 (Reuters) – U.S. health officials are investigating reports that Moderna Inc’s (MRNA.O) COVID-19 vaccine may […]
Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling
PUBLISHED THU, AUG 19 20211:44 PM EDTUPDATED THU, AUG 19 20216:27 PM EDT Authors: Berkeley Lovelace Jr.@BERKELEYJR KEY POINTS Scientists sharply criticized the Biden administration’s push to widely distribute Covid […]
Delta is surging, but is another variant on the way? Here’s what to know about lambda
Ben Sessoms, The Charlotte Observer The delta variant is by far the dominant strain of the coronavirus in North Carolina and the rest of the country, but experts say there […]
US Covid-19 Breakthrough Infections-are-Uncommon Rising Considerably and D-19 Breakthrough Infections are Uncommon, Rising Considerably, and Sort of Okay
Authors: PETER WEBER 5:20 AM The Biden administration is advising eight-month booster shots for Americans vaccinated with the Pfizer and Moderna COVID-19 vaccines because the Delta variant, which now accounts for about 98.8 […]
Covid Vaccines Are Less Effective Against Delta, Large Study Finds Naomi Kresge Bookmark August 19 2021, 4:31 AM
Authors: Naomi Kresge Copyright © BloombergQuintCopyright © Covid-19 vaccines are less effective against the delta variant, according to results in the U.K. from one of the largest real-world studies into […]
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Authors: Julio Vallejos, Rodrigo Zoni, María Gabriela Aguirre Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease […]
Post-acute COVID-19 syndrome
Authors: Ani Nalbandian, Kartik Sehgal, Elaine Y. Wan Nature Medicine volume 27, pages601–615 (2021) Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted […]
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Authors: JACC State-of-the-Art ReviewAzita H. Talasaz, PharmD,a,bParham Sadeghipour, MD,cHessam Kakavand, PharmD,a,bMaryam Aghakouchakzadeh, PharmD,aElaheh Kordzadeh-Kermani, PharmD,aBenjamin W. Van Tassell, PharmD,d,eAzin Gheymati, PharmD,aHamid Ariannejad, MD,bSeyed Hossein Hosseini, PharmD,aSepehr Jamalkhani,cMichelle Sholzberg, MDCM, MSc,f,gManuel Monreal, […]